Trial Profile
Effectiveness of intravitreal ranibizumab combined with a oral supplement rich in docosahexaenoic acid (DHA) plus antioxidants in patients with diabetic macular edema, a randomised, single blind contolled study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2020
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Antioxidants; Docosahexaenoic acid
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 23 Jan 2018 New trial record